Early-stage idiopathic Parkinson’s disease is associated with reduced circular RNA expression

Benjamin J. Whittle,Osagie G. Izuogu,Hannah Lowes,Dasha Deen,Angela Pyle,Jon Coxhead,Rachael A. Lawson,Alison J. Yarnall,Michael S. Jackson,Mauro Santibanez-Koref,Gavin Hudson

DOI: https://doi.org/10.1038/s41531-024-00636-y

2024-01-20

Abstract:Abstract Neurodegeneration in Parkinson’s disease (PD) precedes diagnosis by years. Early neurodegeneration may be reflected in RNA levels and measurable as a biomarker. Here, we present the largest quantification of whole blood linear and circular RNAs (circRNA) in early-stage idiopathic PD, using RNA sequencing data from two cohorts (PPMI = 259 PD, 161 Controls; ICICLE-PD = 48 PD, 48 Controls). We identified a replicable increase in TMEM252 and LMNB1 gene expression in PD. We identified novel differences in the expression of circRNAs from ESYT2 , BMS1P1 and CCDC9 , and replicated trends of previously reported circRNAs. Overall, using circRNA as a diagnostic biomarker in PD did not show any clear improvement over linear RNA, minimising its potential clinical utility. More interestingly, we observed a general reduction in circRNA expression in both PD cohorts, accompanied by an increase in RNASEL expression. This imbalance implicates the activation of an innate antiviral immune response and suggests a previously unknown aspect of circRNA regulation in PD.

neurosciences